Background Early diagnosis of hepatocellular carcinoma (HCC) can significantly improve
patient survival. We aimed to develop a blood‐based assay to aid in the diagnosis, detection …

Early detection improves hepatocellular carcinoma (HCC) outcomes, but better noninvasive
surveillance tools are needed. We aimed to identify and validate methylated DNA markers …

Background Early detection of primary liver cancer (PLC) in patients with liver cirrhosis (LC)
or chronic hepatitis virus infection (CHVI) improves survival. The urgent need is convenient …

Background Aberrant DNA methylation may offer opportunities in revolutionizing cancer
screening and diagnosis. We sought to identify a non-invasive DNA methylation-based …

Aim: This study exploited hepatocellular carcinoma (HCC)-specific circulating DNA
methylation profiles to improve the accuracy of a current screening assay for HCC patients in …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and has a
poor prognosis. Epigenetic modification has been shown to be deregulated during HCC …

Hepatocellular Carcinoma (HCC) is one of the most common cancers in the world and it is
often associated with poor prognosis. Liver transplantation and resection are two currently …

4103 Background: Hepatocellular carcinoma (HCC) is one of the most common and lethal
cancers worldwide, especially in Asian counties. Patients can be treated more effectively if …

Simple Summary Hepatocellular carcinoma (HCC) remains a significant cause of cancer-
related deaths worldwide. Although most HCC cases have a background of cirrhosis, up to …

Hepatocellular carcinoma (HCC) is amongst the cancers with highest mortality rates and is
the most common malignancy of the liver. Early detection is vital to provide the best …